noninferior

VEGF Trap-Eye was also "noninferior" to Lucentis in terms of the average change in vision after one year.

NYT > Home Page By ANDREW POLLACK 2010

DES "noninferior" to MIDCAB for isolated LAD disease, small study suggests Red yeast rice reduces LDL-cholesterol levels in statin-intolerant patients verify here.

theHeart.org 2009

The definition of "noninferior" in the trial was problematic as well, said Susan Bressler,

MedPageToday.com - medical news plus CME for physicians 2009

Robert M. Califf , vice chancellor at Duke University Medical Center and a principal investigator in the J&J-Bayer trial, said patients on the drug got results that were "noninferior," or statistically comparable to those on warfarin treatment.

FDA Panel Backs Xarelto for Stroke Prevention Thomas M. Burton 2011

And even that study has come under attack because the benefits of the Charite in the context of a noninferiority trial, were shown to be noninferior to Bagby and Kuslich cages (BAK), used in spinal fusion, a failed procedure critics say that has not been performed in years.

Johnson & Johnson Chirate Spinal Disc Under Fire 2006

The trial found that remote monitoring was noninferior to in-office visits for the primary endpoint of cumulative survival free of major adverse events HR 0.91, CI 0.68-1.23, p

Forbes.com: News Larry Husten 2011

The study actually called rivaroxaban "noninferior" to warfarin, a double negative that must have made executives at Johnson & Johnson, parent of rivaroxaban, want to weep.

NPR Topics: News 2011

Thus, although the trial was technically a success because it demonstrated that rivaroxaban was noninferior to warfarin, this finding does "not take into account other factors, such as the quality of anticoagulation in the warfarin arm."

unknown title 2011

Although rivaroxaban was noninferior to warfarin in the pivotal ROCKET trial, warfarin was not used as skillfully in ROCKET as in RE-LY and other recent trials, thereby making it difficult to assess the true efficacy of rivaroxaban.

Forbes.com: News Larry Husten 2011

The trial found that remote monitoring was noninferior to in-office visits for the primary endpoint of cumulative survival free of major adverse events HR 0.91, CI 0.68-1.23, p

unknown title 2011